{"id":18895,"date":"2025-12-22T07:49:12","date_gmt":"2025-12-22T07:49:12","guid":{"rendered":"https:\/\/negatius.biz\/?p=18895"},"modified":"2025-12-22T07:49:12","modified_gmt":"2025-12-22T07:49:12","slug":"president-trump-announced-agreements-with-nine-major-pharmaceutical-companies-to-lower-u-s-prescription-drug-prices-by-aligning-costs-with-those-in-other-wealthy-nations-and-offering-discounts-throug","status":"publish","type":"post","link":"https:\/\/negatius.biz\/?p=18895","title":{"rendered":"President Trump announced agreements with nine major pharmaceutical companies to lower U.S. prescription drug prices by aligning costs with those in other wealthy nations and offering discounts through a new TrumpRx platform, aiming to reduce costs for Medicaid and cash\u2011pay patients."},"content":{"rendered":"

President Donald Trump announced on Friday that his administration has reached new agreements with nine major pharmaceutical companies<\/strong> aimed at lowering prescription drug prices in the United States. Speaking at the White House, Trump framed the deals as a significant win for consumers who long have paid far more for medications than patients in other wealthy countries. He described the changes as part of a broader effort to overhaul what he characterizes as an unfair pharmaceutical pricing system and to bring U.S. costs in line with lower international benchmarks.<\/p>\n

Central to the agreements is a \u201cmost favored nation\u201d pricing model<\/strong>. Under this approach, participating drugmakers agree to sell their medications\u2014both to the government (such as Medicaid) and to certain Americans\u2014at prices no higher than those charged in other developed countries. Trump emphasized that this strategy would immediately make drugs more affordable and prevent companies from charging Americans disproportionately high rates simply because of the size and profitability of the U.S. market.<\/p>\n

The nine companies involved in Friday\u2019s announcement include Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi. These firms agreed to restructure pricing for key medications and to offer certain drugs at globally competitive rates. In return, the administration provided incentives such as a three\u2011year reprieve from potential pharmaceutical tariffs<\/strong> and commitments to invest in U.S. manufacturing and research.<\/p>\n

The agreements also lay the groundwork for expanded direct\u2011to\u2011consumer access to lower prices. A new federal platform, TrumpRx.com<\/strong>, is set to launch in early 2026 to help uninsured and cash\u2011pay patients purchase medications at discounted prices negotiated under these deals. For example, one White House briefing cited specific price cuts for drugs like Merck\u2019s diabetes medication, which could be offered substantially below current U.S. list prices through the TrumpRx system.<\/p>\n

This latest round of deals builds on earlier actions by the administration aimed at reducing drug costs. In past months, Trump had pressed a larger group of drugmakers to adopt most\u2011favored\u2011nation pricing and reached voluntary agreements with companies such as Pfizer, AstraZeneca, Eli Lilly, and Novo Nordisk. In some of these earlier deals, prices for high\u2011cost medications\u2014including weight\u2011loss and diabetes drugs\u2014were substantially reduced when sold through direct\u2011to\u2011consumer channels.<\/p>\n

While the White House and Trump cast these agreements as historic victories, questions remain about how broadly and how quickly savings will reach patients<\/strong>. Critics note that tying prices to international benchmarks and implementing new platforms involves complex logistics and may take time before consumers see noticeable decreases at the pharmacy. Additionally, industry observers have pointed out that while Medicaid and uninsured populations may benefit directly, the overall impact on the wider healthcare system and drug innovation remains to be fully assessed.<\/p>\n","protected":false},"excerpt":{"rendered":"

President Donald Trump announced on Friday that his administration has reached new agreements with nine major pharmaceutical companies aimed at lowering prescription drug prices in the United… <\/p>\n","protected":false},"author":2,"featured_media":18896,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-18895","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"\nPresident Trump announced agreements with nine major pharmaceutical companies to lower U.S. prescription drug prices by aligning costs with those in other wealthy nations and offering discounts through a new TrumpRx platform, aiming to reduce costs for Medicaid and cash\u2011pay patients. - magazine24<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/negatius.biz\/?p=18895\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"President Trump announced agreements with nine major pharmaceutical companies to lower U.S. prescription drug prices by aligning costs with those in other wealthy nations and offering discounts through a new TrumpRx platform, aiming to reduce costs for Medicaid and cash\u2011pay patients. - magazine24\" \/>\n<meta property=\"og:description\" content=\"President Donald Trump announced on Friday that his administration has reached new agreements with nine major pharmaceutical companies aimed at lowering prescription drug prices in the United...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/negatius.biz\/?p=18895\" \/>\n<meta property=\"og:site_name\" content=\"magazine24\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-22T07:49:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/negatius.biz\/wp-content\/uploads\/2025\/12\/599950417_122192811536373335_1054850902225975343_n.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"501\" \/>\n\t<meta property=\"og:image:height\" content=\"540\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sk.Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sk.Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/negatius.biz\/?p=18895\",\"url\":\"https:\/\/negatius.biz\/?p=18895\",\"name\":\"President Trump announced agreements with nine major pharmaceutical companies to lower U.S. prescription drug prices by aligning costs with those in other wealthy nations and offering discounts through a new TrumpRx platform, aiming to reduce costs for Medicaid and cash\u2011pay patients. - magazine24\",\"isPartOf\":{\"@id\":\"http:\/\/negatius.biz\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/negatius.biz\/?p=18895#primaryimage\"},\"image\":{\"@id\":\"https:\/\/negatius.biz\/?p=18895#primaryimage\"},\"thumbnailUrl\":\"https:\/\/negatius.biz\/wp-content\/uploads\/2025\/12\/599950417_122192811536373335_1054850902225975343_n.jpg\",\"datePublished\":\"2025-12-22T07:49:12+00:00\",\"author\":{\"@id\":\"http:\/\/negatius.biz\/#\/schema\/person\/ce7debb966dda59a6da4ebe878923a74\"},\"breadcrumb\":{\"@id\":\"https:\/\/negatius.biz\/?p=18895#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/negatius.biz\/?p=18895\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/negatius.biz\/?p=18895#primaryimage\",\"url\":\"https:\/\/negatius.biz\/wp-content\/uploads\/2025\/12\/599950417_122192811536373335_1054850902225975343_n.jpg\",\"contentUrl\":\"https:\/\/negatius.biz\/wp-content\/uploads\/2025\/12\/599950417_122192811536373335_1054850902225975343_n.jpg\",\"width\":501,\"height\":540},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/negatius.biz\/?p=18895#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/negatius.biz\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"President Trump announced agreements with nine major pharmaceutical companies to lower U.S. prescription drug prices by aligning costs with those in other wealthy nations and offering discounts through a new TrumpRx platform, aiming to reduce costs for Medicaid and cash\u2011pay patients.\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/negatius.biz\/#website\",\"url\":\"http:\/\/negatius.biz\/\",\"name\":\"magazine24\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/negatius.biz\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"http:\/\/negatius.biz\/#\/schema\/person\/ce7debb966dda59a6da4ebe878923a74\",\"name\":\"Sk.Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/negatius.biz\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/de3e79686b16c005ec69d61203c42cbc56db9e6a47269911d3b26b6f2d704973?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/de3e79686b16c005ec69d61203c42cbc56db9e6a47269911d3b26b6f2d704973?s=96&d=mm&r=g\",\"caption\":\"Sk.Admin\"},\"url\":\"https:\/\/negatius.biz\/?author=2\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"President Trump announced agreements with nine major pharmaceutical companies to lower U.S. prescription drug prices by aligning costs with those in other wealthy nations and offering discounts through a new TrumpRx platform, aiming to reduce costs for Medicaid and cash\u2011pay patients. - magazine24","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/negatius.biz\/?p=18895","og_locale":"en_US","og_type":"article","og_title":"President Trump announced agreements with nine major pharmaceutical companies to lower U.S. prescription drug prices by aligning costs with those in other wealthy nations and offering discounts through a new TrumpRx platform, aiming to reduce costs for Medicaid and cash\u2011pay patients. - magazine24","og_description":"President Donald Trump announced on Friday that his administration has reached new agreements with nine major pharmaceutical companies aimed at lowering prescription drug prices in the United...","og_url":"https:\/\/negatius.biz\/?p=18895","og_site_name":"magazine24","article_published_time":"2025-12-22T07:49:12+00:00","og_image":[{"width":501,"height":540,"url":"https:\/\/negatius.biz\/wp-content\/uploads\/2025\/12\/599950417_122192811536373335_1054850902225975343_n.jpg","type":"image\/jpeg"}],"author":"Sk.Admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Sk.Admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/negatius.biz\/?p=18895","url":"https:\/\/negatius.biz\/?p=18895","name":"President Trump announced agreements with nine major pharmaceutical companies to lower U.S. prescription drug prices by aligning costs with those in other wealthy nations and offering discounts through a new TrumpRx platform, aiming to reduce costs for Medicaid and cash\u2011pay patients. - magazine24","isPartOf":{"@id":"http:\/\/negatius.biz\/#website"},"primaryImageOfPage":{"@id":"https:\/\/negatius.biz\/?p=18895#primaryimage"},"image":{"@id":"https:\/\/negatius.biz\/?p=18895#primaryimage"},"thumbnailUrl":"https:\/\/negatius.biz\/wp-content\/uploads\/2025\/12\/599950417_122192811536373335_1054850902225975343_n.jpg","datePublished":"2025-12-22T07:49:12+00:00","author":{"@id":"http:\/\/negatius.biz\/#\/schema\/person\/ce7debb966dda59a6da4ebe878923a74"},"breadcrumb":{"@id":"https:\/\/negatius.biz\/?p=18895#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/negatius.biz\/?p=18895"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/negatius.biz\/?p=18895#primaryimage","url":"https:\/\/negatius.biz\/wp-content\/uploads\/2025\/12\/599950417_122192811536373335_1054850902225975343_n.jpg","contentUrl":"https:\/\/negatius.biz\/wp-content\/uploads\/2025\/12\/599950417_122192811536373335_1054850902225975343_n.jpg","width":501,"height":540},{"@type":"BreadcrumbList","@id":"https:\/\/negatius.biz\/?p=18895#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/negatius.biz\/"},{"@type":"ListItem","position":2,"name":"President Trump announced agreements with nine major pharmaceutical companies to lower U.S. prescription drug prices by aligning costs with those in other wealthy nations and offering discounts through a new TrumpRx platform, aiming to reduce costs for Medicaid and cash\u2011pay patients."}]},{"@type":"WebSite","@id":"http:\/\/negatius.biz\/#website","url":"http:\/\/negatius.biz\/","name":"magazine24","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/negatius.biz\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"http:\/\/negatius.biz\/#\/schema\/person\/ce7debb966dda59a6da4ebe878923a74","name":"Sk.Admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/negatius.biz\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/de3e79686b16c005ec69d61203c42cbc56db9e6a47269911d3b26b6f2d704973?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/de3e79686b16c005ec69d61203c42cbc56db9e6a47269911d3b26b6f2d704973?s=96&d=mm&r=g","caption":"Sk.Admin"},"url":"https:\/\/negatius.biz\/?author=2"}]}},"_links":{"self":[{"href":"https:\/\/negatius.biz\/index.php?rest_route=\/wp\/v2\/posts\/18895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/negatius.biz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/negatius.biz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/negatius.biz\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/negatius.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=18895"}],"version-history":[{"count":1,"href":"https:\/\/negatius.biz\/index.php?rest_route=\/wp\/v2\/posts\/18895\/revisions"}],"predecessor-version":[{"id":18897,"href":"https:\/\/negatius.biz\/index.php?rest_route=\/wp\/v2\/posts\/18895\/revisions\/18897"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/negatius.biz\/index.php?rest_route=\/wp\/v2\/media\/18896"}],"wp:attachment":[{"href":"https:\/\/negatius.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=18895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/negatius.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=18895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/negatius.biz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=18895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}